Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2012
03/08/2012CA2809443A1 Novel antigen binding proteins
03/08/2012CA2809391A1 4-{[(pyridin-3-yl-methyl)aminocarbonyl]amino}benzene-sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
03/08/2012CA2809178A1 Tyrosine kinase inhibitors
03/08/2012CA2808908A1 Combination of hdac inhibitors with thrombocytopenia drugs
03/08/2012CA2807620A1 Pharmaceutically active compounds as axl inhibitors
03/08/2012CA2806273A1 Pure erlotinib
03/07/2012EP2426150A1 Anti-NKG2A antibodies and uses thereof
03/07/2012EP2426149A1 Anti-cadherin antibody
03/07/2012EP2426148A1 Anti-il-3ra antibody for use in treatment of blood tumor
03/07/2012EP2426139A1 CXCR4 antagonist and use thereof
03/07/2012EP2426130A1 Purine derivative and antitumor agent using same
03/07/2012EP2426129A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
03/07/2012EP2426106A1 Piperidine and Piperazine derivatives for the treatment of tumours
03/07/2012EP2425874A2 Use of a vitamin D compound and an additional therapeutic agent for the treatment of cancer
03/07/2012EP2425861A1 Radioactively labeled substance
03/07/2012EP2425849A2 Compositions and methods using anti-CS1 antibodies to treat multiple myeloma
03/07/2012EP2425838A2 Combination therapy for treatment of immune disorders
03/07/2012EP2425835A1 A new medical use of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate and natural flavonoid derivatives
03/07/2012EP2425831A1 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
03/07/2012EP2425830A1 Synergistic drug combination for the treatment of cancer
03/07/2012EP2425818A1 Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof
03/07/2012EP2424990A2 Compositions and methods for enhancing antigen-specific immune responses
03/07/2012EP2424977A1 Microglial precursor cells for the treatment of malignant neoplasms of the central nervous system
03/07/2012EP2424898A1 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
03/07/2012EP2424873A1 Novel galactoside inhibitors of galectins
03/07/2012EP2424868A1 Cdk inhibitor salts
03/07/2012EP2424864A1 Oxazole substituted indazoles as pi3-kinase inhibitors
03/07/2012EP2424859A1 Inhibitors of pi3 kinase and / or mtor
03/07/2012EP2424849A1 Salt of abt-263 and solid-state forms thereof
03/07/2012EP2424843A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
03/07/2012EP2424571A2 Gene vector
03/07/2012EP2424569A1 Anti-mesothelin immunoconjugates and uses therefor
03/07/2012EP2424560A1 Compounds and methods for modulating an immune response
03/07/2012EP2424554A1 Novel sphingosine kinase type 1 inhibitors, compositions and processes for using same
03/07/2012EP2424544A1 Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
03/07/2012EP2424537A1 Substituted imidazoquinoxalines
03/07/2012EP2424536A2 Novel photosensitizer formulations for oral administration
03/07/2012EP2424532A1 Compounds for inducing cellular apoptosis
03/07/2012EP2424524A1 Treatment or prophylaxis of proliferative conditions
03/07/2012EP2424368A1 Pyrrolotriazine compounds
03/07/2012EP2424351A1 Anti-cancer drugs, and uses relating for malignant melanoma and other cancers
03/07/2012EP2213674B1 Purification method of pemetrexed salts,sodium salts and disodium salts
03/07/2012EP2207786B1 2'-fluoro-2'-deoxytetrahydrouridines as cytidine deaminase inhibitors
03/07/2012EP2186830B1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof
03/07/2012EP2111402B1 Aminopyrazole kinase inhibitors
03/07/2012EP2080512B1 Anti-cancer agent
03/07/2012EP2047256B1 A method for the in vitro screening of anti-cancer compounds that inhibits sk3 activity, and said anti-cancer compounds
03/07/2012EP1962850B1 Treatment of drug-resistant tumors
03/07/2012EP1961767B1 Diagnosis and treatment of cancers and other conditions
03/07/2012EP1919891B1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
03/07/2012EP1773884B1 Therapeutic and diagnostic methods and compositions targeting 4ig-b7-h3 and its counterpart nk cell receptor
03/07/2012EP1768966B1 Coumpounds and methods for inhibiting the interaction of bcl proteins with binding partners
03/07/2012EP1767546B1 Angiogenesis-inhibiting chimeric protein and the use
03/07/2012EP1692184B1 Antibodies that bind interleukin-4 receptor
03/07/2012EP1542667B1 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
03/07/2012EP1446412B1 Novel lna compositions and uses thereof
03/07/2012EP1355923B1 Immunomodulatory peptides derived from heat shock proteins and uses thereof
03/07/2012EP1255738B1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/07/2012CN1954845B Sarcandra compound medical composite and its preparation method
03/07/2012CN1943648B A plant medicine for treatment of primary hepatic carcinoma and its preparation method and use
03/07/2012CN1854125B Aryl-group-substituted acrylonitrile compound, its production and use
03/07/2012CN1636069B Method of determining a chemotherapeutic regimen based on ERCCI expression
03/07/2012CN102369283A Rnai molecule for thymidylate synthase and use thereof
03/07/2012CN102369281A HLA-A24-binding cancer antigen peptide derived from SOX2
03/07/2012CN102369242A Polyion complex comprising hydrophobized polyamino acid and use of same
03/07/2012CN102369219A Antibodies against human tweak and uses thereof
03/07/2012CN102369218A Anti-fcrh5 antibodies and immunoconjugates and methods of use
03/07/2012CN102369216A Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same
03/07/2012CN102369204A 3-deazaneplanocin derivatives
03/07/2012CN102369200A Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
03/07/2012CN102369195A Autotaxin inhibitors
03/07/2012CN102369192A Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
03/07/2012CN102369191A Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
03/07/2012CN102369187A N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
03/07/2012CN102369011A Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
03/07/2012CN102369010A Treatment regimen utilizing neratinib for breast cancer
03/07/2012CN102366628A Quality stabilization technique of antitumor protein medicines
03/07/2012CN102366627A Protein sensitizer of tumor chemotherapeutics
03/07/2012CN102366569A Method for preparing manganese silicon alloy
03/07/2012CN102366522A Chinese medicine pill for treating esophageal cancer and process technology
03/07/2012CN102366518A Method for ultrasonic assisted aqueous two-phase extraction of total dioscin
03/07/2012CN102366499A Chinese herbal medicine for treating stomach cancer
03/07/2012CN102366492A Chinese herbal medicine for treating esophagus cancer
03/07/2012CN102366491A Chinese herbal medicine for treating breast cancer
03/07/2012CN102366464A Antitumor traditional Chinese medicinal composition
03/07/2012CN102366417A Application of protopanoxadiol in preparation of antitumor medicaments
03/07/2012CN102366416A Pharmaceutical application of 12-dehydroxy-21-hydroxy protopanoxadiol
03/07/2012CN101984964B Application of T-2 toxin to preparing drugs for treating renal cell carcinomas
03/07/2012CN101797392B Palladium-103 and io-125 compound sealed seed source, source core and source core preparation method
03/07/2012CN101676306B Low molecular weight glucan and preparation method and application thereof
03/07/2012CN101543614B Cancer treating oral liquid and preparation method thereof
03/07/2012CN101543472B Method for preparing oxaliplatin sustained release suppository
03/07/2012CN101433691B Zedoary turmeric oil extract as well as preparation method and application thereof
03/07/2012CN101433612B Effective component of Chinese dittany bark as well as preparation method and use thereof
03/07/2012CN101400679B Spiroindolinone derivatives
03/07/2012CN101343421B Preparation method for pH controlled releasedynamic polymer packaging system
03/07/2012CN101322719B Arsenic trioxide solid lipid nano granule and formulation
03/07/2012CN101243084B Pyrrolo[2,3-B]pyridine derivatives as protein kinase inhibitors
03/07/2012CA2714253A1 Directed radiotherapy
03/06/2012US8129552 for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium
1 ... 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 ... 2211